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Mussaenda erythrophylla (Rubiaceae) is native to 
western tropical Africa, occasionally seen in gardens and 
parks as ornamental plant in India. The Hepatoprotective 
activity of ethyl acetate and methanol extracts of 
M.erythrophylla (ME) Stem against carbon tetrachloride 
(CCl4) induced liver damage in Wistar albino rats. Ethyl 
acetate and methanolic extracts of ME 
(100,200mg/kg.p.o.), were administerd respectively, 
Silymarin (25 mg/kg.p.o.) was given as reference 










the liver against the injury induced by CCl4 in animals. 
This was evident from significant reduction in serum 
enzyme, SGOT, SGPT, ALP and Total bilirubin 
(TB).Various pathological changes like centribular 
necrosis and vacuolization were observed in CCL4 treated 
rats, which were significant protective activity in groups 
treated with ME and silymarin. It was concluded from 
the study that   ethyl acetate and methanolic extracts of 
ME possess hepatoprotective activity against CCl4 
induced hepatotoxicity in rats. 
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Mussaenda erythrophylla (Rubiaceae) is native 
to western tropical Africa, occasionally seen in gardens 
and parks as ornamental plant in India and is commonly 
known as mussenda (telugu), nagavalli (Sanskrit) and red 
flag bush (English)1. It is a perennial, evergreen shrub 
with branched tap root system. The roots are useful for 
cough, jaundice and when chewed acts as an appetizer. A 
number of triterpenoids and glycosides were reported. 
mussaenda genus viz., contains mussaendosides U(1) 
and V(2)2, mussaendosides G(1) and K(2) are two new 
triterpenoid saponins3, mussaendosides A-C, M and N 
with cyclolanostene type aglycone 4-5 and 
aureusidin6,iridoid glycosides7. The pharmacological 
activities reported from Mussaenda species were diuretic, 
antiphlogistic, antipyretic and effective in 
laryngopharyngitis, acute gastroenteritis and dysentery 
and also anti-fertility activity8. The evaluation of the 
stem of M.erythrophylla in the treatment of liver disease 
has not been reported in the laboratory animals. The 
present studies were performed to assess the 
hepatoprotective activity in rats against carbon 
tetrachloride as hepatotoxin to prove its claim in the 
folklore practices against liver disorders.   
 




The stem of Mussaenda erythrophylla was 
procured from M.V.P colony, Visakhapatnam, in the 
month of April 2006, (Voucher number TSN/DOP/ME 
0406). The authentification of the plant was done by 
prof. M. Venkaiah, Dept. of Botany, Andhra University, 
Visakhapatnam.  
 
PREPARATION OF EXTRACT 
  
Freshly collected plant material was shade 
dried at room temperature and coarsely powdered in 
Wiely mill. The powdered stem (1kg) was extracted 
successively with hexane, ethyl acetate and methanol 
using soxhlet apparatus. The crude extract was 
evaporated to dryness in a rotary film evaporator 
(Roteava,Equitron, Medica instrument, India ) and found 
to be 2.5 gms, 30 gms and 25gms respectively. 
Preliminary phytochemical screening of ethyl acetate 
extract of M. erythrophylla stem revealed the presence of   
steroids, triterpenoids and flavonoids; methanol extract 
tested positive for glycosides, tannins and saponins. 
  
The constituents present in the ethyl acetate 
and methanol extracts of M.erythrophylla stem initiated 
to carry out the hepatoprotective activity. The ethyl 
acetate and methanol extracts were subjected to 
hepatoprotective activity in rats. Silymarin was used as 
positive control at dose of 25mg/kg.p.o. All the test 
substances were suspended in vehicle i.e. 5% acacia 
mucilage. The extracts were tested for activity at doses of 
100mg/kg and 200mg/kg.p.o. 
 
DRUG AND CHEMICALS  
 
CCl4 was obtained from Poona Chemical 
Laboratory, Pune, India. Silymarin-Microlab, Bangalore, 
Karnataka, India. Estimation kits-Span Diagnostics, 
Surat, India. All other chemicals were obtained from 
local sources (Sai chemicals, Visakhapatnam) and were 




`Wistar albino rats of either sex weighing 
between 200-250 gm were obtained from M/s. Mahavir 
Enterprises, Hyderabad. The animals were housed under 
standard environmental conditions (temperature of 22  
1°C with an alternating 12 h light – dark cycle and 
relative humidity of 60  5%), one week before the start 
and also during the experiment as per the rules and 
regulations of the Institutional Ethics Committee and by 
animal regulatory body of the government (Regd: No: 
516/01/A/CPCSEA). They were fed with standard 
laboratory diet supplied by M/s. Rayans biotechnologies 




ACUTE TOXICITY STUDIES  
 
Acute toxicity studies were performed for 
extracts according to the toxic classic method as per 
OECD guidelines9. Female albino rats were used for the 
acute toxicity study. The animals were kept fasting 
overnight providing only water, after which the extracts 
were administered orally at the dose of 300 mg/kg and 
observed for 14 days. If mortality was observed in 2 out 
of 3 animals, then the dose administered was assigned as 
toxic dose. If the mortality was observed in 1 animal, 
then the same dose was repeated again to confirm the 
toxic dose. If the mortality was not observed, the 
procedure was repeated for further higher dose i.e., 2000 










The animals were divided into seven groups of 
six animals each. Group-I served as normal control 
received 5% acacia mucilage (1 ml/kg.p.o) daily once   
for 7 days. Group-II served as toxic control and received 
CCl4 (0.5 ml/kg i.p) daily once for 7 days
10.  Group-III 
was treated with the reference drug Silymarin (25 mg/kg 
.p.o) and followed by CCl4 (0.5 ml/kg i.p)   daily once 
for 7 days11. Groups IV-V were treated with methanol 
extract of M.erythrophylla stem at doses of 100 and 200 
mg/kg p.o. in acacia mucilage respectively followed by 
CCl4 (0.5 ml/kg i.p) daily once for 7 days. Groups VI-VII 
were treated with ethyl acetate extract of M.erythrophylla 
stem at doses of 100 and 200 mg/kg p.o, in acacia 
mucilage respectively followed by CCl4 (0.5 ml/kg i.p)   
daily once for 7 days. After completion of treatment 
blood was collected, serum was separated and used for 
determination of biochemical parameters. 
 
COLLECTION OF BLOOD SAMPLES 
  
All the  animals were sacrificed on 7th day 
under light ether anesthesia.The blood samples  were 
collected separately in sterilized dry centrifuge tubes by 
puncture retro-orbital plexes and allowed to coagulate for 
30 min at 37 °C .The clear serum was separated at 2500 
rpm (Microcentrifuge) for 10min and subjected to 
biochemical investigation viz..,serum glutamic 
oxaloacetate  transe aminase (SGOT), serum glutamic 
Pyruvate  transe aminase (SGPT), Alkaline phosphatase 
(ALP) and Total Bilirubin (TB ).  
 
ASSESSMENT OF LIVER FUNCTION 
 
The Serum glutamic oxaloacetic transaminase 
(SGOT) and serum glutamic pyruvic transaminase 
(SGPT) were estimated by UV kinetic method  in which 
both SGOT and SGPT were assayed based on enzyme-
coupled system; where keto acid formed by the 
aminotransaminase reacts in a system using NADH.The 
coenzyme is oxidized to NAD and the decrease in 
absorbance at 340 nm for SGOT  malate dehydrogenase 
(MDH) reduces to malate with simultaneous oxidation of 
NADH to NAD.The rate of oxidation of NADH is 
measured, where  as SGPT 12 the pyruvate formed in the 
reaction is converted to lactate by lactate 
dehydrogenase.Estimation of Alkaline phosphate 
(ALKP)13 involves  hydrolysis of P-nitrophenyl 
phosphate by alkaline phosphatase to give P- 
nitrophenol, which gives yellow color in alkaline 
solution. The increase in absorbance due to its formation 
is directly proportional to alkaline phosphate (ALKP) 
activity. Estimation of total bilirubin (TB) 14 involved the 
reaction of bilirubin with diazotized sulphanic acid to 
form an azocompound, the color of which is measured at 
546 nm .All the estimations were carried out using 
standard kits in semi auto analyzer Screen Master 3000. 
 
HISTOPATHOLOGICAL STUDIES  
 The isolated liver specimens were trimmed to 
small pieces and preserved in formalin (10%) solution for 
24 hrs. The liver specimens were subjected to 
dehydration with acetone of strength 70, 80, 100 % 
respectively, each for one hour. The infiltration and 
impregnation was done by treatment with paraffin wax 
twice each time for one hour. Specimens were cut into 
sections of 4-6 µm thickness and were stained with 
haemotoxylin and eosin (H-E) and later the microscopic 






Results of biochemical estimation were  
reported as mean ±SEM  for determination of significant 
inter group difference was analysed separately and one-
way analysis  of variance (ANOVA) was  carried 
out15.Dunnet’s test was used for indidual comparisons16. 
 
RESULTS 
 The LD 50 of ethyl acetate extract and methanol 
soluble extracts were found to be 2000 mg/kg .b.w. 1/10th 
and 1/20th of these doses (200 mg/kg. b.w, and 
100mg/kg. b.w) were selected for the evaluation of 
hepatoprotective activity. 
  
The effect of ethyl acetate  and methanol 
extracts of M.erythrophylla stem on CCl4 induced liver 
damage in rats with reference to biochemical changes in 
serum is shown in table.(1). Percentage decrease or 
increase was calculated by 
considering the enzyme level difference 
between hepatotoxin treated and control rats as 100% of 
level of reduction and recorded in (Table- 2).The 
comparative efficacy of  the extracts and silymarin tested 
for their hepatoprotective activity were depicted in the 
form of a bar diagram fig(1). 
  
Histopathology of liver tissues (a) Group I — 
section shows central vein surrounded by hepatic cord of 
cells (normal architecture). (b) Group II—section shows 
patches of liver cell necrosis with inflammatory 
collections, around central vein. (c) Group III—almost 
near normal. (d) Group IV—inflammatory collections 
around central vein and focal necrosis with sinusoidal 
dilatation. (e) Group V—less inflammatory cells around 
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central vein, absence of necrosis. (f) Group VI—less 
inflammation around dilated central vein. (g) Group 
VII—minimal inflammatory cellular infiltration. Almost 
near normal liver architecture. Regeneration of 




















Control  123.83±1.70 82.66±1.54 158.33±2.20 1.06±0.08 
CCL4  0.5 ml/kg.b.w  997.66±22.74 736.0±17.57 488.48±8.23 4.48±0.17 
Sylimarin 100mg/kg  223.16±1.40 164.50±1.60 185.16±2.80 1.7±0.13 
MEME 100mg/kg  485.16±1.88 395.16±2.57 373.83±1.53 3.25±0.07 
MEME 200mg/kg  429.33±0.88 314.83±1.19 315.5±1.25 2.63±0.13 
EEME 100mg/kg  419.16±1.07 341.16±1.19 287.5±1.72 2.78±0.04 
EEME 200mg/kg  365.66±1.20 285.66±1.33 245.33±1.22 2.33±0.08 
 
 
EEME –Ethyl acetate extract of Mussaenda erythrophylla, MEME-Methanol extract of Mussaenda erythrophylla, Values 
are expressed in mean ± SEM,  n=6, in each group. **Significant increase compared to Control (P≤0.01), ***Significant 







Percentage decrease in levels of biochemical parameters due to treatment with different 
Extracts of of M.erythrophylla stem. 
 
 




Treated with          % Decrease Biochemical Levels 
   SGOT  SGPT  ALP  TB 
 
Silymarin 25mg/kg     83.63               87.47                91.87               81.28 
MEME 100mg/kg  58.64            52.16  34.72              35.96 
MEME 200mg/kg  65.03            64.46  52.39  54.09 
EEME100mg/kg  66.20            60.43  60.87              49.70 
EEME 200mg/kg  72.32              68.92                 61.53                 62.86 
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Comparative hepatoprotective activity of ethyl acetate and  methanol 




















































Figure (a) Representative photographs of histopathological changes showing effect of the test material on the rats intoxicated 
with carbon tetrachloride. a. normal control, b.Carbontetrachloride 0.5ml/kg.i.p., c. silymarin 25mg/kg.p.o., d,e. Methanolic 
extract (100mg/kg,200mg/kg.p.o.,),  f,g. ethyl acetate extract (100mg/kg,200mg/kg..p.o.) 
  
                                                                    
                             Fig(a) 
                                         
                                        Fig(b)                                              Fig(c) 
                                      
                               Fig(d)                                                             Fig(e)                                                                            
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DISCUSSION AND CONCLUSION 
 
The carbon tetrachloride mechanism begins 
with the trichloromethyl radical (·CCl3) by the action of 
the mixed function of   cytochrome P-450 oxygenase 
system. This free radical, which is initially formed as 
unreactive, reacts  very rapidly with oxygen to yield a 
highly reactive trichloromethyl  peroxy radical 
(·OOCCl3). Both radicals are capable of binding to 
proteins, lipids or abstracting a hydrogen atom an 
unsaturated lipid, thus initiating lipid peroxydation. This 
proceses of lipid peroxidation can significantly damage 
hepatic plasma membranes17.The increased levels of 
SGOT,SGPT,ALP and TB are conventional indicators of 
liver injury18.The ability of hepatoprotective drug to 
reduce the injurious effect or to preserve the normal 
hepatic physiological mechanisms, that have been 
disturbed by a hepatotoxin, is the index of its protective 
effect19. Hepatocellular necrosis leads to evaluation of 
the serum marker enzymes, which are released from the 
liver in blood20.The present study revealed a significant 
increase in the activities of SGOT,SGPT,ALP and TB 
levels on exposure to CCl4 indicating  considerable 
hepatocellular injury. Administration of both ethyl 
acetate extracand methanol extracts at two different dose 
levels attenuated the  increased levels of the serum 
enzymes, produced by CCl4 and caused a subsequent 
recovery towords normalization  almost like that of 
silymarin  treatment. 
  
 
The hepatoprotective effect of the drugs was 
further concluded by the histopathological examinations 
of the liver sections which reveal that the normal liver 
architecture was distrurbed by hepatotoxin intoxication. 
In the liver sections of the rats treated with   ethyl acetate 
extract and methnolic extract and intoxicated with CCl4 
the normal cellular architecture was retained as compared 
to silymarin, thereby confirming the protective effect of 
the extracts of M. erythrophylla. 
 
               Accordance with these results, ethyl acetate 
extract and methanolic extract at different dose levels 
offer hepatoprotection dose dependent activity. But 
Group VII (ethyal acetate extract 200mg/kg.b.w.p.o) is 
more effective than all other groups and it may be 
hypothesized that rich content of flvonoids may be 
responsible. The hepatoprotective activity of these drugs 
might be due to stabilization of the membrane inhibiting 
effect on lipid peroxidation or due to their stimulatory 
effects on hepatic regeneration. The protective action 
may be due to scavenging effect of free radicles. 
Hepatoprotective action of certain phytoconstituents like 
flavonoids21-22, saponins23, triterpenoids24, has been well 
documented in the literature.The author some 
phytoconstituents like 5- hydroxy-7, 4’-dimethoxy 
flavones, β-sitosterol,3- iso cumaryloxy – cyclopropane-
1-oic acid,4 -hydroxy-3-methaxy cinnamic acid25,  was 
isolated from ethyl acetate extract of M.erythrophylla 
these phytoconstituents are alone or in combination 
responsible for hepatoprotective activity In conclusion 
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